Key result
Supranormal left ventricular ejection fraction (>65%) appears to be associated with an elevated risk of major adverse cardiovascular events, particularly in women.
Why the study?
The prognostic implications of supranormal left ventricular ejection fraction in cardiovascular disease, particularly heart failure, and its association with MACE needed assessment.
Does supranormal left ventricular ejection fraction increase the risk of major adverse cardiovascular events in patients with cardiovascular disease?
Systematic Review
Does supranormal left ventricular ejection fraction increase the risk of major adverse cardiovascular events in patients with cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Supranormal left ventricular ejection fraction (>65%) may be associated with an increased risk of major adverse cardiovascular events, particularly in women, suggesting a U-shaped relationship between LVEF and mortality.
This systematic review aims to assess the prognostic implications of supranormal left ventricular ejection fraction (snLVEF) in cardiovascular disease, particularly heart failure (HF), and explore its association with major adverse cardiovascular events (MACE). A comprehensive search of electronic databases was conducted to identify relevant studies examining the relationship between snLVEF and cardiovascular outcomes. Studies utilizing various imaging modalities, including echocardiography, cardiac positron emission tomography, computed tomography, and cardiac magnetic resonance imaging, were included. Data extraction and quality assessment were performed according to predefined criteria. The review identified several studies investigating the association between snLVEF and cardiovascular outcomes. Findings revealed an increased risk of MACE, including HF hospitalization and stroke, in patients with snLVEF, particularly in women. Coronary microvascular dysfunction and autonomic dysregulation were proposed mechanisms underlying these associations. However, conflicting results were observed when focusing exclusively on snLVEF, with some studies reporting similar outcomes between snLVEF and other HF subgroups. snLVEF (>65%) appears to be associated with an elevated risk of MACE, particularly in women, suggesting a U-shaped mortality curve. However, the prognostic implications may vary among HF patients, necessitating further research to elucidate the specific contributions of HF phenotypes and comorbidities. These findings underscore the importance of tailored risk assessment and management strategies for patients with snLVEF, particularly in the context of HF.
No takes yet. Share an insight, caveat, or question.
Rahim et al. (2024) conducted a systematic review in Cardiovascular disease, particularly heart failure. Supranormal left ventricular ejection fraction (>65%) vs. Normal LVEF or other HF subgroups was evaluated on Major adverse cardiovascular events (MACE), including HF hospitalization and stroke. Supranormal left ventricular ejection fraction (>65%) appears to be associated with an elevated risk of major adverse cardiovascular events, particularly in women.
Synapse has enriched 10 related papers. Consider them for comparative context: